Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anjana A. Kulkarni
Observed name:
Anjana Kulkarni
Observed institutions:
Guy's Hospital,
St Thomas' Hospital,
Guy's and St Thomas' NHS Foundation Trust,
London North West Healthcare NHS Trust,
The Royal Free Hospital,
University College London
show all 6
OpenAlex ID:
A5111983114
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study
2021
·
Elizabeth K Bancroft
, Elizabeth C Page
, et al.
·
The Lancet Oncology
·
99
PDF
Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
2009
·
Anjana A. Kulkarni
, Sarah R. Kingsbury
, et al.
·
Clinical Cancer Research
·
73
PDF
Vestibular schwannomas occur in schwannomatosis and should not be considered an exclusion criterion for clinical diagnosis
2011
·
Miriam J. Smith
, Anjana Kulkarni
, et al.
·
American Journal of Medical Genetics Part A
·
65
DNA Replication Licensing Factors and Aurora Kinases are Linked to Aneuploidy and Clinical Outcome in Epithelial Ovarian Carcinoma
2007
·
Anjana A. Kulkarni
, Marco Loddo
, et al.
·
Clinical Cancer Research
·
55
UK consensus recommendations for clinical management of cancer risk for women with germline pathogenic variants in cancer predisposition genes: RAD51C, RAD51D, BRIP1 and PALB2
2022
·
Helen Hanson
, Anjana Kulkarni
, et al.
·
Journal of Medical Genetics
·
51
PDF
Prospective analysis of 895 patients on a UK Genomics Review Board
2019
·
David Allan Moore
, Marina Kushnir
, et al.
·
ESMO Open
·
32
Reclassification of clinically-detected sequence variants: Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK)
2022
·
Lucy Loong
, Alice Garrett
, et al.
·
Genetics in Medicine
·
30
The avoiding late diagnosis of ovarian cancer (ALDO) project; a pilot national surveillance programme for women with pathogenic germline variants inBRCA1andBRCA2
2022
·
Sue Philpott
, Maria Raikou
, et al.
·
Journal of Medical Genetics
·
19
PDF
The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource
2024
·
Catherine Huntley
, Lucy Loong
, et al.
·
EClinicalMedicine
·
16
PDF
Prenatal diagnosis and pre‐implantation genetic diagnosis for cancer susceptibility conditions
2021
·
Anjana Kulkarni
, Mark David Kilby
·
BJOG An International Journal of Obstetrics & Gynaecology
·
5
PDF
Structural Aberrations with Secondary Implications (SASIs): consensus recommendations for reporting of cancer susceptibility genes identified during analysis of Copy Number Variants (CNVs)
2019
·
Sabrina Talukdar
, Lara Hawkes
, et al.
·
Journal of Medical Genetics
·
5
Prenatal and pre‐implantation genetic testing for monogenic disorders for germline cancer susceptibility gene variants: UK joint consensus guidance
2023
·
Mohamed Wafik
, Mark David Kilby
, et al.
·
BJOG An International Journal of Obstetrics & Gynaecology
·
4
Multiple outcomes of the germline p16INK4a mutation affecting senescence and immunity in human skin
2024
·
Priya Subramanian
, Souraya Sayegh
, et al.
·
Aging Cell
·
3
PDF
Genodermatoses – Opportunities for Early Detection and Cancer Prevention
2022
·
Helena Carley
, Anjana Kulkarni
·
Current Genetic Medicine Reports
·
3
PDF
Aspirin for cancer prevention in individuals with Lynch syndrome: first results from the CaPP3 multicentre, randomised, double-blind, non-inferiority trial
2026
·
John Burn
, Gillian M Borthwick
, et al.
·
The Lancet. Gastroenterology & hepatology
·
2
Reproductive decision-making in cancer susceptibility syndromes
2024
·
Helena Carley
, Anjana Kulkarni
·
Best Practice & Research Clinical Obstetrics & Gynaecology
·
2
Identification and functional validation of a novel pathogenic POT1 germline variant p.G95V in familial melanoma
2024
·
Farrah Bakr
, Anjana Kulkarni
, et al.
·
JEADV Clinical Practice
·
1
PDF
Experiences of patients and public partners in codesign of Lynch Choices™: an evaluation study using the Patient Engagement In Research Scale (PEIRS-22)
2026
·
Kelly Kohut
, Lesley Turner
, et al.
·
Research Involvement and Engagement
Prenatal and pre-implantation genetic testing for monogenic disorders for germline cancer susceptibility gene variants: summary of the UK British Society for Genetic Medicine joint consensus guidance
2024
·
Mohamed Wafik
, Anjana Kulkarni
·
Obstetrics Gynaecology & Reproductive Medicine
Supplementary Data from Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
2023
·
Anjana A. Kulkarni
, Sarah R. Kingsbury
, et al.
Data from Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
2023
·
Anjana A. Kulkarni
, Sarah R. Kingsbury
, et al.
Data from Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
2023
·
Anjana A. Kulkarni
, Sarah R. Kingsbury
, et al.
Supplementary Data from Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma
2023
·
Anjana A. Kulkarni
, Sarah R. Kingsbury
, et al.
PDF
Genomics makes prostate cancer personal
2022
·
Anjana Kulkarni
, Mohamed Wafik
·
Trends in Urology & Men s Health
PDF
Aberrant regulation of the DNA replication licensing system and Aurora kinases in epithelial ovarian carcinoma
2009
·
Anjana Kulkarni
·
OpenGrey (Institut de l'Information Scientifique et Technique)
Show more works
View as search
Works count:
25
Citation count:
464
H-index:
9
I10-index:
9
Year
Topic
Type
